Segerstrom Science Symposium: "Embracing Medical Discovery Today, Training Scientists for Tomorrow"
|
|
|||||||
|
|
Azusa Pacific University continues with the second symposium in its three-part series on issues in the world of science with "Embracing Medical Discovery Today, Training Scientists for Tomorrow," a conversation with medical researchers and practitioners about the latest medical breakthroughs. The symposium takes place on Thursday, January 14, 2010.
The keynote address, "The Challenge of Translational Science," will be delivered by David Baltimore, Ph.D., a Nobel Prize laureate and influential leader in the fields of virology, gene therapy, and AIDS and cancer research. Claire Pomeroy, M.D., MBA, vice chancellor for human health sciences and dean of the School of Medicine at UC Davis, also joins the symposium as a contributing expert and speaker.
A panel discussion will include Pomeroy as well as the following experts:
- James Miser, M.D., former CEO, City of Hope Medical Center; pediatric oncologist
- Aja Lesh, Ph.D., RN, NP, dean, School of Nursing, Azusa Pacific University
- Jon Milhon, Ph.D., professor, Department of Biology and Chemistry, Azusa Pacific University
WHEN AND WHERE:
Thursday, January 14, 2010
Panel discussion: 2–3:30 p.m., Perry Lecture Hall, Segerstrom Science Center, West Campus
Keynote address: 4–5 p.m., Upper Turner Campus Center (UTCC), East Campus
Student reception: 5–6 p.m., Upper Turner Campus Center (UTCC), East Campus
For more information, please contact Andrea McAleenan at amcaleenan@apu.edu or (626) 815-5327.
Meet the Experts:
Keynote Speaker David Baltimore, Ph.D., is an accomplished researcher, educator, administrator, and public advocate for science and engineering, and is considered one of the world’s most influential biologists. Awarded the Nobel Prize at the age of 37 for research in virology, Baltimore has profoundly influenced national science policy on such issues as recombinant DNA research and the AIDS epidemic. His present research focuses on control of inflammatory and immune responses as well as on the use of gene therapy methods to treat HIV and cancer in a program called “Engineering Immunity.”
Born in New York City, Baltimore served as a faculty member at Massachusetts Institute of Technology for nearly 30 years and as president of the California Institute of Technology for nine years. He received his B.A. in Chemistry from Swarthmore College in 1960 and a Ph.D. in 1964 from Rockefeller University.
Baltimore’s numerous honors include the 1970 Gustave Stern Award in Virology, 1971 Eli Lilly and Co. Award in Microbiology and Immunology, 1999 National Medal of Science, and 2000 Warren Alpert Foundation Prize. He was elected to the National Academy of Sciences in 1974, and is also a fellow of the American Academy of Arts and Sciences, and a foreign member of both the Royal Society of London and the French Academy of Sciences. From 2006 through 2009, he served as President-Elect, President and Chair of the American Association for the Advancement of Science (AAAS). He has published more than 600 peer-reviewed articles.
Claire Pomeroy, M.D., MBA, serves as vice chancellor for human health sciences and dean of the School of Medicine at University of California Davis. She is an expert in infectious diseases and a professor of internal medicine, microbiology, and immunology. She oversees the UC Davis Health System, which includes the Betty Irene Moore School of Nursing, a physician practice group, and the UC Davis Medical Center.
Having earned her bachelor's and medical degrees from the University of Michigan, Dr. Pomeroy then completed her residency and fellowship training in internal medicine and infectious diseases at the University of Minnesota. She also earned an MBA from the University of Kentucky. She held faculty positions at both of those institutions before moving to UC Davis.
Dr. Pomeroy leads an active research team studying host responses to infectious diseases. She is a long-time advocate for patients with HIV/AIDS and has a special interest in health care policy. She has published more than 100 articles and book chapters and edited two books.